Non-invasive methods for monitoring airway inflammation: A comparison of expenditures, gain and clinical value;Nichtinvasive verfahren zum nachweis der atemwegsentzündung im vergleich kosten - nutzen - wertigkeit

Pneumologie

Volumn 58, Issue 7, 2004, Pages 510-515

  Holz, O ^a   Jorres R A ^a  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL; EXHALATION; GERMANY; HUMAN; INSURANCE; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SPUTUM EXAMINATION;

AIRWAY OBSTRUCTION; BREATH TESTS; HUMANS; INFLAMMATION; MONITORING, PHYSIOLOGIC; NITRIC OXIDE; SPUTUM;

EID: 3943102028     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818533     Document Type: Review

References (32)

1. Bickerman HA, Sproul EE, Barach AL. An aerosol method of producing bronchial secretions in human subjects: a clinical technique for the detection of lung cancer. Dis Chest 1958; 33: 347-362
2. Pin I, Gibson PG, Kolendowicz R et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-29
3. Gustafsson LE, Leone AM, Persson MG et al. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181: 852-857
4. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 1368-1370
5. Djukanovic R, Sterk PJ, Fahy JV et al. Standardised methodology of sputum induction and processing. Eur Respir J 2002; 20: 1S-55S
6. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J 1997; 10: 1683-1693
7. ATS. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. Am J Respir Crit Care Med 1999; 160: 2104-2117
8. Jörres RA. Modelling the production of nitric oxide within the human airways. Eur Respir J 2000; 16: 555-560
9. Jayaram L, Parameswaran K, Sears MR et al. Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J 2000; 16: 150-158
10. Gibson PG, Henry RL, Thomas P. Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J 2000; 16: 1008-1015
11. Magnussen H, Holz O, Sterk PJ et al. Noninvasive methods to measure airway inflammation: future considerations. Eur Respir J 2000; 16: 1175-1179
12. Kharitonov SA, Barnes PJ. Clinical aspects of exhaled nitric oxide. Eur Respir J 2000; 16: 781-792
13. Holz O, Kips J, Magnussen H. Update on sputum methodology. Eur Respir J 2000; 16: 355-359
14. Gessner C, Hammerschmidt S, Kuhn H et al. [Expired diagnosis? - The potential of exhaled breath analysis]. Pneumologie 2004; 58: 230-237
15. Holz O, Mücke M, Zarza P et al. Freezing of homogenized sputum samples for intermittent storage. Clin Exp Allergy 2001; 31: 1328-1331
16. Green RH, Brightling CE, McKenna S et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715-1721
17. Jayaram L, Hussack P, Boulet LP et al. The LOMA Study. Effect on Asthma Exacerbations in the First Year. Am J Respir Crit Care Med 2003; 167: A976
18. Grootendorst DC, Sont JK, Willems LN et al. Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy 1997; 27: 769-779
19. Pizzichini E, Pizzichini MM, Efthimiadis A et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317
20. Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997; 155: 449-453
21. Holz O, Mücke M, Paasch K et al. Repeated ozone exposures enhance bronchial allergen responses in subjects with rhinitis or asthma. Clin Exp Allergy 2002; 32: 681-689
22. Pizzichini MM, Pizzichini E, Clelland L et al. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med 1997; 155: 1501-1508
23. Smith AD, Cowan JO, Filsell S et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004; 169: 473-478
24. Grönke L, Kanniess F, Holz O et al. The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease. Clin Exp Allergy 2002; 32: 57-63
25. Jones SL, Kittelson J, Cowan JO et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001; 164: 738-743
26. Wodehouse T, Kharitonov SA, Mackay IS et al. Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia. Eur Respir J 2003; 21: 43-47
27. Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol 2002; 110: 28-34
28. Effros RM, Hoagland KW, Bosbous M et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med 2002; 165: 663-669
29. Hunt JF, Fang K, Malik R et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000; 161: 694-699
30. Schleiss MB, Holz O, Behnke M et al. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J 2000; 16: 1115-1118
31. Van Hoydonck PG, Wuyts WA, Vanaudenaerde BM et al. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. Eur Respir J 2004; 23: 189-192
32. 2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic Biol Med 2001; 30: 178-186